New insights into manganese toxicity and speciation

Journal of Trace Elements in Medicine and Biology

Volumn 28, Issue 2, 2014, Pages 106-116

  Michalke, Bernhard ^a   Fernsebner, Katharina ^a  

^a INSTITUTE OF EPIDEMIOLOGY   (Germany)

Author keywords

Manganism; Mn exposure; Mn molecular interactions; Mn biomonitoring; Mn speciation

Indexed keywords

ACETYLCHOLINESTERASE; MANGANESE; MANGANESE SUPEROXIDE DISMUTASE; NEUROTRANSMITTER; REACTIVE OXYGEN METABOLITE; CATALASE; GLUTAMATE AMMONIA LIGASE; GLUTATHIONE PEROXIDASE; MEMBRANE PROTEIN; METAL TRANSPORTER PROTEIN; MONOCARBOXYLATE TRANSPORTER; ORGANIC ANION TRANSPORTER; SUPEROXIDE DISMUTASE; TRANSFERRIN RECEPTOR; UNCLASSIFIED DRUG;

BIOACCUMULATION; BIOLOGICAL MONITORING; CONCENTRATION (PARAMETERS); ENVIRONMENTAL EXPOSURE; HIGH RISK INFANT; HUMAN; MOLECULAR INTERACTION; NERVE CELL LESION; NEUROTOXICITY; NONHUMAN; OCCUPATIONAL EXPOSURE; OCCUPATIONAL HAZARD; PRIORITY JOURNAL; REVIEW; TOXICITY TESTING; CELLS; DRUG EFFECTS; ENVIRONMENTAL MONITORING; EPIDEMIOLOGY; METABOLISM; TOXICITY; BLOOD BRAIN BARRIER; ENZYME ACTIVITY; MEDICAL RESEARCH; MOLECULAR GENETICS; PROTEIN EXPRESSION; TRANSPORT AT THE CELLULAR LEVEL;

CELLS; ENVIRONMENTAL MONITORING; EPIDEMIOLOGIC STUDIES; HUMANS; MANGANESE;

EID: 84898044856     PISSN: 0946672X     EISSN: 18783252     Source Type: Journal    
DOI: 10.1016/j.jtemb.2013.08.005     Document Type: Review

References (105)

1. Dobson A.W., Weber S., Dorman D.C., Lash L.K., Erikson K.M., Aschner M. Oxidative stress is induced in the rat brain following repeated inhalation exposure to manganese sulfate. Biol Trace Elem Res 2003, 93(1-3):113-126.
2. Flynn M.R., Susi P. Neurological risks associated with manganese exposure from welding operations - a literature review. Int J Hyg Environ Health 2009, 212(5):459-469.
3. Yokel R.A. Manganese flux across the blood-brain barrier. Neuromol Med 2009, 11(4):297-310.
4. Lucchini R.G., Martin C.J., Doney B.C. From manganism to manganese-induced parkinsonism: a conceptual model based on the evolution of exposure. Neuromol Med 2009, 11(4):311-321.
5. Aschner J.L., Aschner M. Nutritional aspects of manganese homeostasis. Mol Aspects Med 2005, 26(4-5):353-362.
6. Aschner M., Erikson K.M., Hernandez E.H., Tjalkens R. Manganese and its role in Parkinson's disease: from transport to neuropathology. Neuromol Med 2009, 11(4):252-266.
7. Aschner M., Guilarte T.R., Schneider J.S., Zheng W. Manganese: recent advances in understanding its transport and neurotoxicity. Toxicol Appl Pharmacol 2007, 221(2):131-147.
8. Yokel R.A., Crossgrove J.S. Manganese toxicokinetics at the blood-brain barrier. Res Rep Health Eff Inst 2004, 119(7-58). [discussion 59-73].
9. Michalke B., Halbach S., Nischwitz V. Speciation and toxicological relevance of manganese in humans. J Environ Monit 2007, 9(7):650.
10. Crossgrove J., Zheng W. Manganese toxicity upon overexposure. NMR Biomed 2004, 17(8):544-553.
11. Post J.E. Manganese oxide minerals: crystal structures and economic and environmental significance. Proc Natl Acad Sci USA 1999, 96(7):3447-3454.
12. EPA. Manganese (CASRN 7439-96-5) [26.08.13]. Integrated Risk Information System. http://www.epa.gov/iris/subst/0373.htm.
13. Environmental Protection Agency C, OH, US. Health assessment document for manganese: final report. 1984.
14. Meranger J.C., Smith D.C. The heavy metal content of a typical Canadian diet. Can J Public Health Revue Canadienne de Sante Publique 1972, 63(1):53-57.
15. Kondakis X.G., Makris N., Leotsinidis M., Prinou M., Papapetropoulos T. Possible health effects of high manganese concentration in drinking water. Arch Environ Health 1989, 44(3):175-178.
16. Woolf A., Wright R., Amarasiriwardena C., Bellinger D. A child with chronic manganese exposure from drinking water. Environ Health Perspect 2002, 110(6):613-616.
17. Bouchard M., Laforest F., Vandelac L., Bellinger D., Mergler D. Hair manganese and hyperactive behaviors: pilot study of school-age children exposed through tap water. Environ Health Perspect 2007, 115(1):122-127.
18. Roychowdhury T., Tokunaga H., Ando M. Survey of arsenic and other heavy metals in food composites and drinking water and estimation of dietary intake by the villagers from an arsenic-affected area of West Bengal, India. Sci Total Environ 2003, 308(1-3):15-35.
19. Frisbie S.H., Ortega R., Maynard D.M., Sarkar B. The concentrations of arsenic and other toxic elements in Bangladesh's drinking water. Environ Health Perspect 2002, 110(11):1147-1153.
20. WHO Guidelines for drinking-water quality. Vol. 2. Health criteria and other supporting information 1996, World Health Organization, Geneva. 2nd ed.
21. Dorman D.C., Struve M.F., James R.A., McManus B.E., Marshall M.W., Wong B.A. Influence of dietary manganese on the pharmacokinetics of inhaled manganese sulfate in male CD rats. Toxicol Sci 2001, 60(2):242-251.
22. Dorman D.C., Struve M.F., Wong B.A. Brain manganese concentrations in rats following manganese tetroxide inhalation are unaffected by dietary manganese intake. Neurotoxicology 2002, 23(2):185-195.
23. Zoni S., Bonetti G., Lucchini R. Olfactory functions at the intersection between environmental exposure to manganese and Parkinsonism. J Trace Elem Med Biol 2012, 26(2-3):179-182.
24. Wang J.D., Huang C.C., Hwang Y.H., Chiang J.R., Lin J.M., Chen J.S. Manganese induced parkinsonism: an outbreak due to an unrepaired ventilation control system in a ferromanganese smelter. Br J Ind Med 1989, 46(12):856-859.
25. Kenangil G., Ertan S., Sayilir I., Ozekmekci S. Progressive motor syndrome in a welder with pallidal T1 hyperintensity on MRI: a two-year follow-up. Mov Disord 2006, 21(12):2197-2200.
26. ACGIH®. TLVs® and BEIs®. ISBN: 978-1-882417-95-7; 2009.
27. Nong A., Teeguarden J.G., Clewell H.J., Dorman D.C., Andersen M.E. Pharmacokinetic modeling of manganese in the rat IV: assessing factors that contribute to brain accumulation during inhalation exposure. J Toxicol Environ Health Part A 2008, 71(7):413-426.
28. Frumkin H., Solomon G. Manganese in the U.S. gasoline supply. Am J Ind Med 1997, 31(1):107-115.
29. Baldwin M., Mergler D., Larribe F., Belanger S., Tardif R., Bilodeau L., Hudnell K. Bioindicator and exposure data for a population based study of manganese. Neurotoxicology 1999, 20(2-3):343-353.
30. Hudnell H.K. Effects from environmental Mn exposures: a review of the evidence from non-occupational exposure studies. Neurotoxicology 1999, 20(2-3):379-397.
31. Kaiser J. Manganese: a high-octane dispute. Science 2003, 300(5621):926-928.
32. Sikk K., Taba P., Haldre S., Bergquist J., Nyholm D., Zjablov G., Asser T., Aquilonius S.M. Irreversible motor impairment in young addicts - ephedrone, manganism or both?. Acta Neurol Scand 2007, 115(6):385-389.
33. Ferraz H.B., Bertolucci P.H., Pereira J.S., Lima J.G., Andrade L.A. Chronic exposure to the fungicide maneb may produce symptoms and signs of CNS manganese intoxication. Neurology 1988, 38(4):550-553.
34. Lucchini R., Zimmerman N. Lifetime cumulative exposure as a threat for neurodegeneration: need for prevention strategies on a global scale. Neurotoxicology 2009, 30(6):1144-1148.
35. Stastny D., Vogel R.S., Picciano M.F. Manganese intake and serum manganese concentration of human milk-fed and formula-fed infants. Am J Clin Nutr 1984, 39(6):872-878.
36. Zatta P., Lucchini R., van Rensburg S.J., Taylor A. The role of metals in neurodegenerative processes: aluminum, manganese, and zinc. Brain Res Bull 2003, 62(1):15-28.
37. Lucchini R.G., Albini E., Benedetti L., Borghesi S., Coccaglio R., Malara E.C., Parrinello G., Garattini S., Resola S., Alessio L. High prevalence of Parkinsonian disorders associated to manganese exposure in the vicinities of ferroalloy industries. Am J Ind Med 2007, 50(11):788-800.
38. Racette B.A., McGee-Minnich L., Moerlein S.M., Mink J.W., Videen T.O., Perlmutter J.S. Welding-related parkinsonism: clinical features, treatment, and pathophysiology. Neurology 2001, 56(1):8-13.
39. Zacco A., Resola S., Lucchini R., Albini E., Zimmerman N., Guazzetti S., Bontempi E. Analysis of settled dust with X-ray fluorescence for exposure assessment of metals in the province of Brescia, Italy. J Environ Monit 2009, 11(9):1579-1585.
40. Squitti R., Gorgone G., Panetta V., Lucchini R., Bucossi S., Albini E., Alessio L., Alberici A., Melgari J.M., Benussi L., Binetti G., Rossini P.M., Draicchio F. Implications of metal exposure and liver function in Parkinsonian patients resident in the vicinities of ferroalloy plants. J Neural Transm 2009, 116(10):1281-1287.
41. Finkelstein M.M., Jerrett M. A study of the relationships between Parkinson's disease and markers of traffic-derived and environmental manganese air pollution in two Canadian cities. Environ Res 2007, 104(3):420-432.
42. Lucchini R.G., Guazzetti S., Zoni S., Donna F., Peter S., Zacco A., Salmistraro M., Bontempi E., Zimmerman N.J., Smith D.R. Tremor, olfactory and motor changes in Italian adolescents exposed to historical ferro-manganese emission. Neurotoxicology 2012, 33(4):687-696.
43. Lucchini R.G., Zoni S., Guazzetti S., Bontempi E., Micheletti S., Broberg K., Parrinello G., Smith D.R. Inverse association of intellectual function with very low blood lead but not with manganese exposure in Italian adolescents. Environ Res 2012, 118:65-71.
44. Bouchard M.F., Sauve S., Barbeau B., Legrand M., Brodeur M.E., Bouffard T., Limoges E., Bellinger D.C., Mergler D. Intellectual impairment in school-age children exposed to manganese from drinking water. Environ Health Perspect 2011, 119(1):138-143.
45. Zota A.R., Ettinger A.S., Bouchard M., Amarasiriwardena C.J., Schwartz J., Hu H., Wright R.O. Maternal blood manganese levels and infant birth weight. Epidemiology 2009, 20(3):367-373.
46. Roels H.A., Bowler R.M., Kim Y., Henn B.C., Mergler D., Hoet P., Gocheva V.V., Bellinger D.C., Wright R.O., Harris M.G., Chang Y., Bouchard M.F., Riojas-Rodriguez H., Menezes J.A., Tellez-Rojo M.M. Manganese exposure and cognitive deficits: a growing concern for manganese neurotoxicity. Neurotoxicology 2012, 33(4):872-880.
47. Ljung K.S., Kippler M.J., Goessler W., Grander G.M., Nermell B.M., Vahter M.E. Maternal and early life exposure to manganese in rural Bangladesh. Environ Sci Technol 2009, 43(7):2595-2601.
48. Barlow B.K., Cory-Slechta D.A., Richfield E.K., Thiruchelvam M. The gestational environment and Parkinson's disease: evidence for neurodevelopmental origins of a neurodegenerative disorder. Reprod Toxicol 2007, 23(3):457-470.
49. Henn B.C., Schnaas L., Ettinger A.S., Schwartz J., Lamadrid-Figueroa H., Hernandez-Avila M., Amarasiriwardena C., Hu H., Bellinger D.C., Wright R.O., Tellez-Rojo M.M. Associations of early childhood manganese and lead coexposure with neurodevelopment. Environ Health Perspect 2012, 120(1):126-131.
50. Bouchard M., Mergler D., Baldwin M., Panisset M., Roels H.A. Neuropsychiatric symptoms and past manganese exposure in a ferro-alloy plant. Neurotoxicology 2007, 28(2):290-297.
51. Rohlman D.S., Lucchini R., Anger W.K., Bellinger D.C., van Thriel C. Neurobehavioral testing in human risk assessment. Neurotoxicology 2008, 29(3):556-567.
52. Couper J. Sur les effets du peroxide de manganèse. J Chim Méd Pharm Toxicol 1837, 3:223-225.
53. Weiss B. Economic implications of manganese neurotoxicity. Neurotoxicology 2006, 27(3):362-368.
54. Josephs K.A., Ahlskog J.E., Klos K.J., Kumar N., Fealey R.D., Trenerry M.R., Cowl C.T. Neurologic manifestations in welders with pallidal MRI T1 hyperintensity. Neurology 2005, 64(12):2033-2039.
55. Bornhorst J., Wehe C.A., Huwel S., Karst U., Galla H-J., Schwerdtle T. Impact of manganese on and transfer across blood-brain and blood-cerebrospinal fluid barrier in vitro. J Biol Chem 2012, 287(21):17140-17151.
56. Bowman A.B., Kwakye G.F., Hernandez E.H., Aschner M. Role of manganese in neurodegenerative diseases. J Trace Elem Med Bio 2011, 25(4):191-203.
57. Nischwitz V., Berthele A., Michalke B. Speciation analysis of selected metals and determination of their total contents in paired serum and cerebrospinal fluid samples: an approach to investigate the permeability of the human blood-cerebrospinal fluid-barrier. Anal Chim Acta 2008, 627(2):258-269.
58. Au C., Benedetto A., Aschner M. Manganese transport in eukaryotes: the role of DMT1. Neurotoxicology 2008, 29(4):569-576.
59. Wang X., Li G.J., Zheng W. Upregulation of DMT1 expression in choroidal epithelia of the blood-CSF barrier following manganese exposure in vitro. Brain Res 2006, 1097(1):1-10.
60. Crossgrove J.S., Yokel R.A. Manganese distribution across the blood-brain barrier III. The divalent metal transporter-1 is not the major mechanism mediating brain manganese uptake. Neurotoxicology 2004, 25(3):451-460.
61. Wang X., Miller D.S., Zheng W. Intracellular localization and subsequent redistribution of metal transporters in a rat choroid plexus model following exposure to manganese or iron. Toxicol Appl Pharmacol 2008, 230(2):167-174.
62. Gitler A.D., Chesi A., Geddie M.L., Strathearn K.E., Hamamichi S., Hill K.J., Caldwell K.A., Caldwell G.A., Cooper A.A., Rochet J.C., Lindquist S. Alpha-synuclein is part of a diverse and highly conserved interaction network that includes PARK9 and manganese toxicity. Nat Genet 2009, 41(3):308-315.
63. Jursa T., Smith D.R. Ceruloplasmin alters the tissue disposition and neurotoxicity of manganese, but not its loading onto transferrin. Toxicol Sci 2009, 107(1):182-193.
64. Stallings W.C., Metzger A.L., Pattridge K.A., Fee J.A., Ludwig M.L. Structure-function relationships in iron and manganese superoxide dismutases. Free Radic Res Commun 1991, 1:2-13. Pt 1:259-268.
65. Chtourou Y., Trabelsi K., Fetoui H., Mkannez G., Kallel H., Zeghal N. Manganese induces oxidative stress, redox state unbalance and disrupts membrane bound ATPases on murine neuroblastoma cells in vitro: protective role of silymarin. Neurochem Res 2011, 36(8):1546-1557.
66. Santos D., Milatovic D., Andrade V., Batoreu M.C., Aschner M., Marreilha dos Santos A.P. The inhibitory effect of manganese on acetylcholinesterase activity enhances oxidative stress and neuroinflammation in the rat brain. Toxicology 2012, 292(2-3):90-98.
67. Milatovic D., Gupta R.C., Yu Y.C., Zaja-Milatovic S., Aschner M. Protective effects of antioxidants and anti-inflammatory agents against manganese-induced oxidative damage and neuronal injury. Toxicol Appl Pharmacol 2011, 256(3):219-226.
68. Liapi C., Zarros A., Galanopoulou P., Theocharis S., Skandali N., Al-Humadi H., Anifantaki F., Gkrouzman E., Mellios Z., Tsakiris S. Effects of short-term exposure to manganese on the adult rat brain antioxidant status and the activities of acetylcholinesterase, (Na,K)-ATPase and Mg-ATPase: modulation by l-cysteine. Basic Clin Pharmacol Toxicol 2008, 103(2):171-175.
69. Lebda M.A., El-Neweshy M.S., El-Sayed Y.S. Neurohepatic toxicity of subacute manganese chloride exposure and potential chemoprotective effects of lycopene. Neurotoxicology 2012, 33(1):98-104.
70. Lai J.C., Leung T.K., Lim L. Differences in the neurotoxic effects of manganese during development and aging: some observations on brain regional neurotransmitter and non-neurotransmitter metabolism in a developmental rat model of chronic manganese encephalopathy. Neurotoxicology 1984, 5(1):37-47.
71. Martinez H., Bonilla E. Water intake and brain choline-acetyltransferase and acetylcholinesterase activities in manganese treated rats. Neurobehav Toxicol Teratol 1981, 3(3):277-280.
72. Fitsanakis V.A., Au C., Erikson K.M., Aschner M. The effects of manganese on glutamate, dopamine and gamma-aminobutyric acid regulation. Neurochem Int 2006, 48(6-7):426-433.
73. Anderson J.G., Cooney P.T., Erikson K.M. Brain manganese accumulation is inversely related to gamma-amino butyric acid uptake in male and female rats. Toxicol Sci 2007, 95(1):188-195.
74. Anderson J.G., Fordahl S.C., Cooney P.T., Weaver T.L., Colyer C.L., Erikson K.M. Manganese exposure alters extracellular GABA, GABA receptor and transporter protein and mRNA levels in the developing rat brain. Neurotoxicology 2008, 29(6):1044-1053.
75. Crooks D.R., Welch N., Smith D.R. Low-level manganese exposure alters glutamate metabolism in GABAergic AF5 cells. Neurotoxicology 2007, 28(3):548-554.
76. Santos D., Batoreu M.C., Almeida I., Ramos R., Sidoryk-Wegrzynowicz M., Aschner M., Marreilha Dos Santos A.P. Manganese alters rat brain amino acids levels. Biol Trace Elem Res 2012, 150(1-3):337-341.
77. Chen M.K., Lee J.S., McGlothan J.L., Furukawa E., Adams R.J., Alexander M., Wong D.F., Guilarte T.R. Acute manganese administration alters dopamine transporter levels in the non-human primate striatum. Neurotoxicology 2006, 27(2):229-236.
78. Guilarte T.R., Chen M.K., McGlothan J.L., Verina T., Wong D.F., Zhou Y., Alexander M., Rohde C.A., Syversen T., Decamp E., Koser A.J., Fritz S., Gonczi H., Anderson D.W., Schneider J.S. Nigrostriatal dopamine system dysfunction and subtle motor deficits in manganese-exposed non-human primates. Exp Neurol 2006, 202(2):381-390.
79. Zhao F., Cai T., Liu M., Zheng G., Luo W., Chen J. Manganese induces dopaminergic neurodegeneration via microglial activation in a rat model of manganism. Toxicol Sci 2008, 107(1):156-164.
80. Bornhorst J., Ebert F., Hartwig A., Michalke B., Schwerdtle T. Manganese inhibits poly(ADP-ribosyl)ation in human cells: a possible mechanism behind manganese-induced toxicity?. J Environ Monit 2010, 12(11):2062.
81. Bornhorst J., Meyer S., Weber T., Boker C., Marschall T., Mangerich A., Beneke S., Burkle A., Schwerdtle T. Molecular mechanisms of Mn induced neurotoxicity: RONS generation, genotoxicity, and DNA-damage response. Mol Nutr Food Res 2013, 57(7):1255-1269.
82. Lima P.D., Vasconcellos M.C., Bahia M.O., Montenegro R.C., Pessoa C.O., Costa-Lotufo L.V., Moraes M.O., Burbano R.R. Genotoxic and cytotoxic effects of manganese chloride in cultured human lymphocytes treated in different phases of cell cycle. Toxicol In Vitro 2008, 22(4):1032-1037.
83. Bornhorst J., Ebert F., Lohren H., Humpf H.U., Karst U., Schwerdtle T. Effects of manganese and arsenic species on the level of energy related nucleotides in human cells. Metallomics: Integr Biomet Sci 2012, 4(3):297-306.
84. Hernandez R.B., Farina M., Esposito B.P., Souza-Pinto N.C., Barbosa F., Sunol C. Mechanisms of manganese-induced neurotoxicity in primary neuronal cultures: the role of manganese speciation and cell type. Toxicol Sci 2011, 124(2):414-423.
85. Roth J.A. Are there common biochemical and molecular mechanisms controlling manganism and parkisonism. Neuromol Med 2009, 11(4):281-296.
86. Higashi Y., Asanuma M., Miyazaki I., Hattori N., Mizuno Y., Ogawa N. Parkin attenuates manganese-induced dopaminergic cell death. J Neurochem 2004, 89(6):1490-1497.
87. Rentschler G., Covolo L., Haddad A.A., Lucchini R.G., Zoni S., Broberg K. ATP13A2 (PARK9) polymorphisms influence the neurotoxic effects of manganese. Neurotoxicology 2012, 33(4):697-702.
88. Masuda M., Braun-Sommargren M., Crooks D., Smith D.R. Golgi phosphoprotein 4 (GPP130) is a sensitive and selective cellular target of manganese exposure. Synapse 2012, 67(5):205-215.
89. Cawte J., Hams G., Kilburn C. Manganism in a neurological ethnic complex in northern Australia. Lancet 1987, 329(8544):1257.
90. Templeton D.M., Ariese F., Cornelis R., Danielsson L.G., Muntau H., Van Leeuwen H.P., Lobinski R. Guidelines for terms related to chemical speciation and fractionation of elements. Definitions, structural aspects, and methodological approaches (IUPAC Recommendations 2000). Pure Appl Chem 2000, 72(8):1453-1470.
91. Michalke B. Manganese speciation using capillary electrophoresis - ICP-mass spectrometry. J Chromatogr A 2004, 1050(1):69-76.
92. Michalke B., Berthele A., Mistriotis P., Ochsenkuhn-Petropoulou M., Halbach S. Manganese speciation in human cerebrospinal fluid using CZE coupled to inductively coupled plasma MS. Electrophoresis 2007, 28(9):1380-1386.
93. Crossgrove J.S., Allen D.D., Bukaveckas B.L., Rhineheimer S.S., Yokel R.A. Manganese distribution across the blood-brain barrier, I. Evidence for carrier-mediated influx of managanese citrate as well as manganese and manganese transferrin. Neurotoxicology 2003, 24(1):3-13.
94. Diederich J., Brielmeier M., Schwerdtle T., Michalke B. Manganese and iron species in Sprague-Dawley rats exposed with MnCl2 center dot 4H(2)O (i.v.). Microchem J 2012, 105:115-123.
95. Michalke B., Lucio M., Berthele A., Kanawati B. Manganese speciation in paired serum and CSF samples using SEC-DRC-ICP-MS and CE-ICP-DRC-MS. Anal Bioanal Chem 2013, 405(7):2301-2309.
96. Nischwitz V., Michalke B. Electrospray ionisation with selected reaction monitoring for the determination of Mn-citrate, Fe-citrate, Cu-citrate and Zn-citrate. Rapid Commun Mass Spectrom 2009, 23(15):2338-2346.
97. Smith D., Gwiazda R., Bowler R., Roels H., Park R., Taicher C., Lucchini R. Biomarkers of Mn exposure in humans. Am J Ind Med 2007, 50(11):801-811.
98. Hoet P., Vanmarcke E., Geens T., Deumer G., Haufroid V., Roels H.A. Manganese in plasma: a promising biomarker of exposure to Mn in welders. A pilot study. Toxicol Lett 2012, 213(1):69-74.
99. Lu L., Zhang L.L., Li G.J., Guo W., Liang W., Zheng W. Alteration of serum concentrations of manganese, iron, ferritin, and transferrin receptor following exposure to welding fumes among career welders. Neurotoxicology 2005, 26(2):257-265.
100. Wright R.O., Amarasiriwardena C., Woolf A.D., Jim R., Bellinger D.C. Neuropsychological correlates of hair arsenic, manganese, and cadmium levels in school-age children residing near a hazardous waste site. Neurotoxicology 2006, 27(2):210-216.
101. Eastman R., Jursa T., Benedetti C., Lucchini R., Smith D. Hair as a biomarker of environmental manganese exposure. Environ Sci Technol 2012, 47(3):1629-1637.
102. Jiang Y.M., Zheng W., Long L.L., Zhao W.J., Li X.R., Mo X.A., Lu J.P., Fu X., Li W.M., Liu S.T., Long Q.Y., Huang J.L., Pira E. Brain magnetic resonance imaging and manganese concentrations in red blood cells of smelting workers: search for biomarkers of manganese exposure. Neurotoxicology 2007, 28(1):126-135.
103. Cowan D.M., Fan Q.Y., Zou Y., Shi X.J., Chen J., Aschner M., Rosenthal F.S., Zheng W. Manganese exposure among smelting workers: blood manganese-iron ratio as a novel tool for manganese exposure assessment. Biomarkers 2009, 14(1):3-16.
104. Cowan D.M., Zheng W., Zou Y., Shi X.J., Chen J., Rosenthal F.S., Fan Q.Y. Manganese exposure among smelting workers: relationship between blood manganese-iron ratio and early onset neurobehavioral alterations. Neurotoxicology 2009, 30(6):1214-1222.
105. Nischwitz V., Berthele A., Michalke B. Rapid size fractionation of metal species in paired human serum and cerebrospinal fluid samples using ultrafiltration with off-line element selective detection. J Anal At Spectrom 2010, 25(7):1130-1137.